A1001 Identification of Opportunities for Saccharomyces boulardii
The objective of this study was to assist our client in assessing the potential opportunities in medicine and related areas for the yeast species Saccharomyces boulardii.
The study provides an overview of the S. boulardii market. This included an analysis of market size (by volume and value), market trends and future growth potential, key market segments, geographic considerations, supply chain characteristics, competitors, key success factors, barriers to entry and an overview of the current IP and technological positions.
This information obtained in this study assisted our client in formulating its strategy for producing higher value speciality products.
The report contains specific recommendations as to the best and most cost-effective approach to the market, and gives advice on other potential strategic approaches.
During the course of the study ~20 contacts were made with S. boulardii producers (both API and food grade), distributors, supplement manufacturers in US, Europe, India, Korea and Brazil. Interviews were conducted with those knowledgeable in the industry.
CPL carried out an extensive search for S. boulardii on the drugs databases and patent and trademark databases in US, Europe, India, Korea and Brazil.
The main contents of the study were based on a large number of other sources including in-house databases, government regulators, trade journals, patent databases, scientific journals and existing reports on the probiotics market in US and Europe.
The data collected were used to assess and analyze the issues above in sufficient depth to allow strategic conclusions to be drawn.
Click to see the contents of the study or look below for an outline.
Table of Contents
- Key success factors
- Barriers to entry
- Gastrointestinal drugs
- Saccharomyces boulardii
- Global market
- US market
- European market
- Indian market
- Brazilian market
- 6 biotech companies
Examples of products containing S. boulardii
Products and prices
- Products containing S. boulardii as drugs
- Abstracts of 25 recent significant scientific papers
- Studies funded by a key player
- Overview of contact views
- 6 yeast producers
- 10 supplement and drugs manufacturers
- 1 other probiotics company
- 22 articles
Patents-IP and technological positions
- Patent abstracts
- AT13 Global Pectin Market Overview
- AV041 Animal Feed, Premixes and Feed Additives Competitive Landscape in Serbia
- AR01 Due Diligence on a Food Service Concepts and Ingredients Provider
- AS12 Market Potential for Supercritical CO2 Extraction
- AS10 Plant Nutrition Technology Opportunities